Dr. Izzy Justice is a Best-Selling Author and the Chief Neuroscience officer at Neuro580, a ground-breaking company focused on addressing Performance and Stress in the workplace. He brings over three decades of experience in Human Capital, Healthcare and Business Consulting. Izzy has worked at Deloitte, Accenture and Cerner. As an Executive Coach, he has coached over 30 CEOs, Executive Teams, and dozens of Chief People Officers to orchestrate unlocking of human potential leveraging Neuroscience as the key competency. He also works with dozens of professional athletes/coaches winning Major Championships and Olympic Gold in 2024. He has authored 10 books; his latest LIFE EXPLAINED - Chasing 10Hz, captures the results of looking at over 18K Brain Scans in the seconds/minutes before a high-performing activity. He is an 8X Half and 5X Full Ironman Finisher. 

Admiral James Stavridis is Partner and Vice Chairman of Carlyle and Chair of the Board of Trustees of The Rockefeller Foundation, following five years as the 12th Dean of The Fletcher School of Law and Diplomacy at Tufts University.  A retired 4-star officer in the U.S. Navy, he led the NATO Alliance in global operations from 2009 to 2013 as Supreme Allied Commander with responsibility for Afghanistan, Libya, the Balkans, Syria, counter piracy, and cyber security.  He also served as Commander of U.S. Southern Command, with responsibility for all military operations in Latin America from 2006-2009. He earned more than 50 medals, including 28 from foreign nations in his 37-year military career.

Earlier in his military career he commanded the top ship in the Atlantic Fleet, winning the Battenberg Cup, as well as a squadron of destroyers and a carrier strike group – all in combat.  In 2016, he was vetted for Vice President by Hillary Clinton and subsequently invited to Trump Tower to discuss a cabinet position in the Trump Administration.

Admiral Stavridis earned a PhD in international relations and has published sixteen books and hundreds of articles in leading journals around the world, including the recent novel “2034: A Novel of the Next World War,” was published in October 2024 which was a New York Times bestseller and “To Risk It All: Nine Conflicts and The Crucible of Decision.” His most recent novel ""2084: A Novel of Future War" was published in May 2026, and “The Admiral’s Bookshelf” was published in March 2025. His 2012 TED talk on global security has close to one million views. Admiral Stavridis is a Bloomberg Opinion columnist and Senior Military Analyst for CNN.

Robert Langer is one of 9 Institute Professors at MIT; being an Institute Professor is MIT’s highest honor. His articles have been cited over 467,000 times; his h-index of 335 is the highest of any engineer in history. His patents have licensed or sublicensed to over 400 companies; he is a cofounder of many companies including Moderna. He holds 45 honorary doctorates and has received over 220 awards, including both the United States National Medals of Science and Technology & Innovation (one of 3 living individuals to have received both honors), and has been elected to the National Academies of Medicine, Engineering, Sciences, and Inventors.

Gavin Baker is the Founder, Managing Partner and Chief Investment Officer of Atreides Management, a Boston-based investment manager focused on technology and consumer sectors, managing approximately $7 billion in assets across a range of funds and strategies that invest primarily in public and private equities. Atreides is built on the belief that the symbiotic relationship between venture and public equity investing is crucial for generating value for investors. Through the firm's crossover strategy, Atreides aims to provide insights into leading edge technology and disruptive threats to incumbents, helping the team to identify the investment implications of secular disruption.

Gavin has over 25 years of experience in investing –spanning market cycles, sectors, stages, and geographies. In addition to overseeing all investments and research at Atreides, he is responsible for the firm’s day-to-day portfolio management. He is also a Director or Observer of multiple Atreides portfolio companies, including Lightbits Labs, WEKA, and Xsight Labs.

Prior to founding Atreides in 2019, Gavin spent 18 years at Fidelity Investments, most recently as the portfolio manager of the Fidelity OTC Portfolio from 2009 to 2017. Gavin was named Fund Manager of the Year in December 2014 by Boston Globe columnist Steven Syre for the Fidelity OTC Portfolio’s performance in 2014 and was recognized by articles in Barron’s, the New York Times, Investor’s Business Daily and the Wall Street Journal. He also helped spearhead Fidelity’s venture capital investing from 2013 to 2017 and was a board observer for various portfolio companies. Prior to managing the Fidelity OTC Portfolio, he was a portfolio manager of the Fidelity Select Wireless Portfolio from 2007 to 2011, the Fidelity Select Telecommunications Portfolio from 2007 to 2009 and the Fidelity Select Pharmaceuticals Portfolio from 2002 to 2005. Gavin started his career at Fidelity as an analyst, and focused on semiconductors, pharmaceuticals, retail, consumer packaged goods and telecommunications.

Gavin earned an A.B. in Economics and History from Dartmouth College.

Michael Carmen is a partner and Co-Head of Private Investments at Wellington Management, where he leads a diversified late-stage growth equity platform investing across technology, consumer, healthcare, and financial services.